Prodrug nanoplatform for triggering ferroptosis to eliminate senescent cells in age-associated pathologies

Posted on
prodrug-nanoplatform-for-triggering-ferroptosis-to-eliminate-senescent-cells-in-age-associated-pathologies
Prodrug nanoplatform for triggering ferroptosis to eliminate senescent cells in age-associated pathologies

References

  1. López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243–278 (2023).

    Google Scholar 

  2. Guo, J. et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct. Target. Ther. 7, 391 (2022).

    Google Scholar 

  3. Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813–827 (2019).

    Google Scholar 

  4. Leeman, D. S. et al. Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging. Science 359, 1277–1283 (2018).

    Google Scholar 

  5. Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246–1256 (2018).

    Google Scholar 

  6. Childs, B. G. et al. Senescent cells: an emerging target for diseases of ageing. Nat. Rev. Drug Discov. 16, 718–735 (2017).

    Google Scholar 

  7. He, S. & Sharpless, N. E. Senescence in health and disease. Cell 169, 1000–1011 (2017).

    Google Scholar 

  8. Hickson, L. J. et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine 47, 446–456 (2019).

    Google Scholar 

  9. Zhu, Y. et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14, 644–658 (2015).

    Google Scholar 

  10. Chang, J. et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med. 22, 78–83 (2015).

    Google Scholar 

  11. Fuhrmann-Stroissnigg, H. et al. Identification of HSP90 inhibitors as a novel class of senolytics. Nat. Commun. 8, 422 (2017).

    Google Scholar 

  12. Guerrero, A. et al. Cardiac glycosides are broad-spectrum senolytics. Nat. Metab. 1, 1074–1088 (2019).

    Google Scholar 

  13. Xu, Q. et al. The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice. Nat. Metab. 3, 1706–1726 (2021).

    Google Scholar 

  14. Rad, A. N. & Grillari, J. Current senolytics: mode of action, efficacy and limitations, and their future. Mech. Ageing Dev. 217, 111888 (2024).

    Google Scholar 

  15. Stockwell, B. R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185, 2401–2421 (2022).

    Google Scholar 

  16. von Krusenstiern, A. N. et al. Identification of essential sites of lipid peroxidation in ferroptosis. Nat. Chem. Biol. 19, 719–730 (2023).

    Google Scholar 

  17. Lei L. et al. Targeting the Labile iron pool with engineered DFO nanosheets to inhibit ferroptosis for Parkinson’s disease therapy. Adv. Mater. 36, e2409329 (2024).

  18. Zhu L. et al. Ferritin-hijacking nanoparticles spatiotemporally directing endogenous ferroptosis for synergistic anticancer therapy. Adv. Mater. 34, e2207174 (2022).

  19. Zou, P. et al. Implanted, wireless, self-powered photodynamic therapeutic tablet synergizes with ferroptosis inducer for effective cancer treatment. Adv. Sci. 10, e2302731 (2023).

    Google Scholar 

  20. Wang, Q. et al. Enzyme-mediated bioorthogonal cascade catalytic reaction for metabolism intervention and enhanced ferroptosis on neuroblastoma. J. Am. Chem. Soc. 146, 8228–8241 (2024).

    Google Scholar 

  21. Du, K. et al. Aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress. Nat. Aging 4, 949–968 (2024).

    Google Scholar 

  22. Noh B. et al. Iron overload induces cerebral endothelial senescence in aged mice and in primary culture in a sex-dependent manner. Aging Cell 22, e13977 (2023).

  23. Maus, M. et al. Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype. Nat. Metab. 5, 2111–2130 (2023).

    Google Scholar 

  24. Admasu T. D. et al. Selective ablation of primary and paracrine senescent cells by targeting iron dyshomeostasis. Cell Rep. 42, 112058 (2023).

  25. Nousis, L., Kanavaros, P. & Barbouti, A. Oxidative stress-induced cellular senescence: is labile iron the connecting link?. Antioxidants 12, 1250 (2023).

    Google Scholar 

  26. Lan M. et al. Photosensitizers for photodynamic therapy. Adv. Healthcare Mater. 8, e1900132 (2019).

  27. Shi, D. et al. Photoactivatable senolysis with single-cell resolution delays aging. Nat. Aging 3, 297–312 (2023).

    Google Scholar 

  28. Vankayala, R. & Hwang, K. C. Near-infrared-light-activatable nanomaterial-mediated phototheranostic nanomedicines: an emerging paradigm for cancer treatment. Adv. Mater. 30, e1706320 (2018).

    Google Scholar 

  29. Wan, Y., Fu, L. H., Li, C., Lin, J. & Huang, P. Conquering the hypoxia limitation for photodynamic therapy. Adv. Mater. 33, e2103978 (2021).

    Google Scholar 

  30. Deng, X., Shao, Z. & Zhao, Y. Solutions to the drawbacks of photothermal and photodynamic cancer therapy. Adv. Sci. 8, 2002504 (2021).

    Google Scholar 

  31. Zhao, H. et al. An energy-storing DNA-based nanocomplex for laser-free photodynamic therapy. Adv. Mater. 34, e2109920 (2022).

    Google Scholar 

  32. Zhao, H. et al. Energy-storing DNA-based hydrogel remodels tumor microenvironments for laser-free photodynamic immunotherapy. Biomaterials 309, 122620 (2024).

    Google Scholar 

  33. Gnaim, S. et al. Direct real-time monitoring of prodrug activation by chemiluminescence. Angew. Chem. Int. Ed. 57, 9033–9037 (2018).

    Google Scholar 

  34. Jiang, G. et al. A selective and light-up fluorescent probe for β-galactosidase activity detection and imaging in living cells based on an AIE tetraphenylethylene derivative. Chem. Commun. 53, 4505–4508 (2017).

    Google Scholar 

  35. Safir Filho, M., Dao, P., Gesson, M., Martin, A. R. & Benhida, R. Development of highly sensitive fluorescent probes for the detection of β-galactosidase activity – application to the real-time monitoring of senescence in live cells. Analyst 143, 2680–2688 (2018).

    Google Scholar 

  36. Coffman, L. G., Parsonage, D., D’Agostino, R., Torti, F. M. & Torti, S. V. Regulatory effects of ferritin on angiogenesis. Proc. Natl. Acad. Sci. 106, 570–575 (2009).

    Google Scholar 

  37. Lazar, A.-N., Perret, F., Perez-Lloret, M., Michaud, M. & Coleman, A. W. Promises of anionic calix[n]arenes in life science: State of the art in 2023. Eur. J. Med. Chem. 264, 115994 (2024).

    Google Scholar 

  38. Ramberg, K. O., Engilberge, S., Skorek, T. & Crowley, P. B. Facile fabrication of protein–macrocycle frameworks. J. Am. Chem. Soc. 143, 1896–1907 (2021).

    Google Scholar 

  39. Mester, L., Govyadinov, A. A., Chen, S., Goikoetxea, M. & Hillenbrand, R. Subsurface chemical nanoidentification by nano-FTIR spectroscopy. Nat. Commun. 11, 3359 (2020).

    Google Scholar 

  40. Gnaim, S. et al. Light emission enhancement by supramolecular complexation of chemiluminescence probes designed for bioimaging. Chem. Sci. 10, 2945–2955 (2019).

    Google Scholar 

  41. Yeung, J. Y. et al. Solvent-dependent supramolecular host-guest assemblies of platinum(II) tweezers and a guest system: from discrete molecules to high-ordered oligomers. Angew. Chem. (Int. ed. Engl.) 61, e202207313 (2022).

    Google Scholar 

  42. Goudarzi, Z. et al. Two-dimensional polycyclodextrins for strong multivalent host-guest interactions at biointerfaces. Small 21, e2412282 (2025).

    Google Scholar 

  43. Swain, S. et al. Photoactive nanocatalysts as DTT-assisted BSA-AuNCs with enhanced oxidase-mimicking ability for sensitive fluorometric detection of antioxidants. J. Nanobiotechnol. 22, 585 (2024).

    Google Scholar 

  44. McKenna, E., Traganos, F., Zhao, H. & Darzynkiewicz, Z. Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence. Cell Cycle 11, 3132–3140 (2014).

    Google Scholar 

  45. Liu, W. et al. Chlorin e6-biotin conjugates for tumor-targeting photodynamic therapy. Molecules 26, 7342 (2021).

    Google Scholar 

  46. Cai, Y. et al. Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell Res. 30, 574–589 (2020).

    Google Scholar 

  47. Zhang H. et al. Senolytic therapy enabled by senescent cell-sensitive biomimetic melanin nano-senolytics. Adv. Healthc. Mater. 13, e2401085 (2024).

  48. Raffaele, M. & Vinciguerra, M. The costs and benefits of senotherapeutics for human health. Lancet Healthy Longev. 3, e67–e77 (2022).

    Google Scholar 

  49. Justice, J. N. et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine 40, 554–563 (2019).

    Google Scholar 

  50. Dhokia, V., Albati, A., Smith, H., Thomas, G. & Macip, S. A second generation of senotherapies: the development of targeted senolytics, senoblockers and senoreversers for healthy ageing. Biochem. Soc. Trans. 52, 1661–1671 (2024).

    Google Scholar 

  51. Chandrakar, L., Ambatwar, R. & Khatik, G. L. Cellular senescence and senolytic agents: recent updates on their role and applications. Curr. Top. Med. Chem. 24, 157–178 (2024).

    Google Scholar 

  52. Sun, B., Bte Rahmat, J. N. & Zhang, Y. Advanced techniques for performing photodynamic therapy in deep-seated tissues. Biomaterials 291, 121875 (2022).

    Google Scholar 

  53. Pezacki, A. T. et al. A tandem activity-based sensing and labeling strategy reveals antioxidant response element regulation of labile iron pools. Proc. Natl. Acad. Sci. 121, e2401579121 (2024).

    Google Scholar 

  54. Zhang S. et al., Self-Illuminating NIR-II chemiluminescence nanosensor for in vivo tracking H2O2 fluctuation. Adv. Sci. 10, 2207651 (2023).

  55. Yang, S. et al. GSH/pH dual activatable cross-linked and fluorinated PEI for cancer gene therapy through endogenous iron de-hijacking and in situ ROS amplification. Adv. Mater. 36, e2304098 (2023).

    Google Scholar 

  56. Nambiar, A. et al. Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability. eBioMedicine 90, 104481 (2023).

    Google Scholar 

  57. Guignabert, C. et al. Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension. J. Clin. Investig. 126, 3207–3218 (2016).

    Google Scholar 

  58. Delval, L. et al. Removal of senescent cells reduces the viral load and attenuates pulmonary and systemic inflammation in SARS-CoV-2-infected, aged hamsters. Nat. Aging 3, 829–845 (2023).

    Google Scholar 

  59. Novais E. J. et al. Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat. Commun. 12, 5213 (2021).

  60. Budamagunta, V. et al. Senolytic treatment alleviates doxorubicin-induced chemobrain. Aging Cell 23, e14037 (2024).

    Google Scholar 

Download references